Zusammenfassung
Antidementiva sind zentral wirkende Substanzen zur Behandlung kognitiver Störungen – insbesondere des Gedächtnisses, der Konzentration und Aufmerksamkeit, des Urteilsvermögens und der Orientierung – und Verbesserung der beeinträchtigten Alltagskompetenz bei Demenzerkrankungen.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Literatur
Brasky TM, Darke AK, Song X et al (2013) Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst 105(15):1132–1141
Cooper C, Li R, Lyketsos C, Livingston G (2013) Treatment for mild cognitive impairment: systematic review. Br J Psychiatry 203:255–264
Jack CR Jr, Albert MS, Knopman DS et al (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7(3):257–262
Lange-Asschenfeldt C (2013) Vaskuläre Faktoren in der Pathogenese der Alzheimer-Krankheit. Nervenarzt 84(6):732–737
Nordström P, Religa D, Wimo A et al (2013) The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease. Eur Heart J 34(33):2585–2591
Porsteinsson AP, Drye LT, Pollock BG et al; CitAD Research Group (2014) Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA. 311(7): 682–691
Rountree SD, Atri A, Lopez OL, Doody RS (2013) Effectiveness of antidementia drugs in delaying Alzheimer's disease progression. Alzheimers Dement 9(3):338–345
Scheltens P, Twisk JW, Blesa R et al (2012) Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J Alzheimers Dis 31(1):225–236
Sperling RA, Aisen PS, Beckett LA et al (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7(3):280–292
Steinberg M, Lyketsos CG (2012) Atypical antipsychotic use in patients with dementia: managing safety concerns. Am J Psychiatry 169(9):900–906
Wu CK, Yang YH, Lin TT et al (2014) Statin use reduces the risk of dementia in elderly patients: a nationwide data survey and propensity analysis. J Intern Med. doi: 10.1111/joim.12262 (Epub ahead of print)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Benkert, O. (2015). Antidementiva. In: Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54769-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-54769-0_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54768-3
Online ISBN: 978-3-642-54769-0
eBook Packages: Medicine (German Language)